# Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects

> **NCT01165450** · PHASE2 · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 2 (actual)

## Conditions studied

- Persistent Corneal Epithelial Defects

## Interventions

- **DRUG:** Nexagon
- **DRUG:** Vehicle only

## Key facts

- **NCT ID:** NCT01165450
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Drug manufacturer could not supply study drug.
- **Last updated:** 2015-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01165450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01165450, "Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01165450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*